[go: up one dir, main page]

AU2003280799A1 - Medicinal composition - Google Patents

Medicinal composition

Info

Publication number
AU2003280799A1
AU2003280799A1 AU2003280799A AU2003280799A AU2003280799A1 AU 2003280799 A1 AU2003280799 A1 AU 2003280799A1 AU 2003280799 A AU2003280799 A AU 2003280799A AU 2003280799 A AU2003280799 A AU 2003280799A AU 2003280799 A1 AU2003280799 A1 AU 2003280799A1
Authority
AU
Australia
Prior art keywords
medicinal composition
medicinal
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003280799A
Inventor
Tetsuro Noguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of AU2003280799A1 publication Critical patent/AU2003280799A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2813Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003280799A 2002-11-15 2003-11-14 Medicinal composition Abandoned AU2003280799A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-332162 2002-11-15
JP2002332162 2002-11-15
PCT/JP2003/014504 WO2004045624A1 (en) 2002-11-15 2003-11-14 Medicinal composition

Publications (1)

Publication Number Publication Date
AU2003280799A1 true AU2003280799A1 (en) 2004-06-15

Family

ID=32321653

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003280799A Abandoned AU2003280799A1 (en) 2002-11-15 2003-11-14 Medicinal composition

Country Status (4)

Country Link
KR (1) KR20040042896A (en)
AU (1) AU2003280799A1 (en)
TW (1) TW200416034A (en)
WO (1) WO2004045624A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034885B2 (en) 2012-01-13 2015-05-19 Acea Biosciences Inc. EGFR modulators and uses thereof
US9464089B2 (en) 2012-01-13 2016-10-11 Acea Biosciences Inc. Heterocyclic compounds and uses thereof
US10799504B2 (en) 2012-01-13 2020-10-13 ACEA Therapeutics, Inc. Heterocyclic compounds and uses as anticancer agents
MX368491B (en) 2013-07-11 2019-10-04 Acea Biosciences Inc Pyrimidine derivatives as kinase inhibitors.
KR20180067584A (en) 2015-10-09 2018-06-20 아세아 테라퓨틱스 인코포레이티드 PHARMACEUTICALS, PHYSICAL FORM AND COMPOSITIONS OF PYRROLOPYRIMIDINE KINASE INHIBITORS AND METHODS FOR THEIR PREPARATION
JP2020516682A (en) 2017-04-07 2020-06-11 エイシア セラピューティクス, インコーポレイテッド Pharmaceutical salts, physical forms and compositions of pyrrolopyrimidine kinase, and methods of making the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63166824A (en) * 1986-12-29 1988-07-11 Toyo Jozo Co Ltd soft capsules
JP2936553B2 (en) * 1992-07-09 1999-08-23 田辺製薬株式会社 Nicergoline-containing tablets
CA2195262C (en) * 1996-01-18 2005-08-09 Masaru Ubasawa Phosphonate nucleotide compounds
JP2002265371A (en) * 1997-04-04 2002-09-18 Chugai Pharmaceut Co Ltd Phosphate-binding polymer preparation
KR20050044587A (en) * 2001-12-07 2005-05-12 미쯔비시 웰 파마 가부시키가이샤 Use of phosphonate nucleotide analogue for treating hepatitis b virus infections

Also Published As

Publication number Publication date
TW200416034A (en) 2004-09-01
KR20040042896A (en) 2004-05-20
WO2004045624A1 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
AU2003291103A1 (en) Pharmaceutical composition
AU2003278393A1 (en) New use for pharmaceutical composition
AU2003285288A1 (en) Composition
AU2003280797A1 (en) Shampoo composition
AU2003250372A1 (en) Pharmaceutical composition
AU2002302147A1 (en) Pharmaceutical composition
AU2002950744A0 (en) Composition
AU2002258221A1 (en) Medicinal composition
AU2003235708A1 (en) Polytartrate composition
AU2003208411A1 (en) Anti-glycolytic composition
AU2003282722A1 (en) Therapeutic compositions
AU2003284460A1 (en) Medicinal composition
AU2003280799A1 (en) Medicinal composition
AU2003216503A1 (en) Stable pharmaceutical compositions
AU2003280678A1 (en) Medicinal composition
AU2002354460A1 (en) Medicinal composition
AU2003242235A1 (en) Antifungal medicinal composition
AU2003268772A1 (en) Oil-barrier composition
AUPR529701A0 (en) Pharmaceutical composition
AUPS188302A0 (en) Pharmaceutical composition
AU2002335161A1 (en) Medicinal composition
AU2003220855A1 (en) Medicinal antitumor composition
AUPS167102A0 (en) Pharmaceutical composition
AUPS124202A0 (en) Pharmaceutical composition
AU2003242346A1 (en) Drug composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase